IJCM> Vol.9 No.6, June 2018

Author(s)

F. Bossali^1*, G. Ndziessi^2*, C. L. Ahoui-Apendi³, G. Deby³, M. J. F. Mimiesse³, J. W. Ombila¹, B. I. Atipo-Ibara³, J. R. Ibara³

¹Department of Gastroenterology, Loandjili General Hospital, Pointe-Noire, Congo-Brazzaville.
²Faculty of Health Sciences, Department of Public Health, Marien Ngouabi University, Brazzaville, Congo.
³Department of Gastroenterology, University Hospital of Brazzaville, Brazzaville, Congo.

Prevalence of hepatitis B in Pointe-Noire is 23%. The objective of this study was to evaluate the level of therapeutic management of patients with hepatitis B in Pointe-Noire. Methods: A retrospective, cross-sectional, descriptive and analytical study. Results: 302 patients included: 217 (72%) men and 85 (28%) women of median age 40 years. The viral load was measured in 140 (46%) patients and in 162 (54%), the viral load was not measured. Their distribution according to the viremia was as follows: 0 - 1 log = 1 (0.7%) patients; 1.5 to 2 log = 23 (16%) patients; 2.5 to 3 log = 49 (35%) patients; >3log = 55 (39%) patients. Of the 302 patients included, 36 (11%) patients were treated with antivirals and 253 (83%) patients were not. Conclusion: The number of patients treated for chronic viral hepatitis B was low. Our results show interest for improved preventive and curative management of hepatitis B in Congo in order to reduce the existing high prevalence.

Access, Congo, Hepatitis B, Pointe-Noire, Treatment

Bossali, F. , Ndziessi, G. , Ahoui-Apendi, C. , Deby, G. , Mimiesse, M. , Ombila, J. , Atipo-Ibara, B. and Ibara, J. (2018) Evaluation of Viral Hepatitis B Treatment in Pointe-Noire in 2016. International Journal of Clinical Medicine, 9, 513-519. doi: 10.4236/ijcm.2018.96044.